Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3014-3026
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3014
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3014
Table 1 Demographics and examination findings of the diabetes patients grouped by the duration of type 2 diabetes mellitus with or without dry eye disease
Parameters | DEwDM | P value | DMnDE | P value | DEwDM versus DMnDE P value | |||
Duration of diabetes ≤ 10 yr | Duration of diabetes > 10 yr | Duration of diabetes ≤ 10 yr | Duration of diabetes > 10 yr | Duration of diabetes ≤ 10 yr | Duration of diabetes > 10 yr | |||
Number [N] | 26 | 30 | 8 | 14 | ||||
Age [yr ± SEM] | 56.8 ± 9.3 | 57.8 ± 6.9 | 0.660 | 51.3 ± 8.9 | 57.1 ± 5.3 | 0.065 | 0.146 | 0.740 |
Gender | 0.126 | 0.074a | 0.257a | 1b | ||||
Male [N (%)] | 13 (50.0) | 21 (70.0) | 2 (25.0) | 10 (71.4) | ||||
Female [N (%)] | 13 (50.0) | 9 (30.0) | 6 (75.0) | 4 (28.6) | ||||
Blood glucose [mmol/L ± SEM] | 7.9 ± 3.7 | 9.6 ± 4.2 | 0.103 | 7.8 ± 1.1 | 9.7 ± 2.8 | 0.083 | 0.926 | 0.989 |
Duration of diabetes [years ± SEM] | 5.9 ± 2.6 | 17.8 ± 4.8 | 0.000 | 8.3 ± 1.7 | 17.6 ± 5.4 | 0.000 | 0.021 | 0.940 |
HbA1c [% ± SEM] | 7.8 ± 2.3 | 8.4 ± 1.8 | 0.257 | 7.7 ± 1.9 | 8.1 ± 1.4 | 0.652 | 0.921 | 0.484 |
BUT [s ± SEM] | 4.1 ± 2.5 | 3.8 ± 2.5 | 0.586 | 11.2 ± 7.5 | 10.0 ± 2.9 | 0.601 | 0.000 | 0.000 |
Schirmer test [mm ± SEM] | 5.9 ± 4.7 | 3.2 ± 3.4 | 0.018 | 18.4 ± 5.9 | 10.9 ± 6.2 | 0.012 | 0.000 | 0.000 |
NFL [mm/mm2 ± SEM] | 17.653 ± 4.569 | 15.851 ± 4.881 | 0.162 | 20.445 ± 4.036 | 15.904 ± 5.238 | 0.047 | 0.131 | 0.974 |
NFD [num/mm2 ± SEM] | 33.2 ± 12.1 | 30.4 ± 8.486 | 0.323 | 39.1 ± 12.4 | 33.9 ± 10.9 | 0.323 | 0.240 | 0.250 |
NBD [num/mm2 ± SEM] | 56.7 ± 25.5 | 50.0 ± 25.2 | 0.326 | 61.7 ± 21.0 | 43.3 ± 22.4 | 0.072 | 0.619 | 0.401 |
R1 [ms] | 11.8 ± 0.9 | 12.2 ± 0.8 | 0.083 | 10.3 ± 0.5 | 11.8 ± 1.0 | 0.001 | 0.000 | 0.183 |
Table 2 Patient characteristics
Parameters | DEwDM | DEnDM | DMnDE | nDMnDE | Statistics |
Number [N] | 56 | 33 | 22 | 20 | |
Age [yr ± SEM] | 56.9 ± 7.8 | 52.3 ± 11.1 | 55.0 ± 7.2 | 52.2 ± 9.4 | |
Gender | chi-square test | ||||
Male [N (%)] | 34 (60.7) | 14 (42.4) | 12 (54.5) | 8 (40.0) | |
Female [N (%)] | 22 (39.3) | 19 (57.6) | 10 (45.5) | 12 (60.0) | |
Blood glucose [mmol/L ± SEM] | 7.4 ± 4.2 | NA | 9.0 ± 2.5 | NA | |
Duration of diabetes [years ± SEM] | 12.3 ± 7.1 | NA | 14.2 ± 6.4 | NA | |
HbA1c [% ± SEM] | 8.1 ± 2.0 | NA | 7.9 ± 1.6 | NA | |
OSDI scores ± SEM | 5.8 ± 3.9b,c | 9.7 ± 6.3a,c | 3.6 ± 2.7a,b,d | 10.5 ± 7.1c | Tamhane test |
BUT [s ± SEM] | 3.9 ± 2.5c,d | 4.9 ± 3.9c,d | 10.4 ± 4.9a,b | 12.0 ± 6.5a,b | Tamhane test |
Schirmer test [mm ± SEM] | 4.5 ± 4.2c,d | 3.7 ± 3.6c,d | 13.6 ± 7.0a,b | 11.2 ± 4.4a,b | Tamhane test |
Table 3 Comparisons for the nerve fiber length, nerve fiber density, nerve branch density, and R1 among four groups
Parameters | DEwDM | DEnDM | DMnDE | nDMnDE | Statistics |
NFL [mm/mm2] | 16.688 ± 4.782d | 16.894 ± 4.855d | 17.555 ± 5.236d | 22.017 ± 3.369a,b,c | Tukey HSD test |
NFD [num/mm2] | 35.0 ± 9.4 | 37.5 ± 10.6 | 35.6 ± 11.3 | 41.3 ± 8.1 | Tukey HSD test |
NBD [num/mm2] | 46.9 ± 23.1 | 51.3 ± 25.0 | 50.0 ± 23.1 | 60.6 ± 26.3 | Tukey HSD test |
R1 [ms] | 12.0 ± 0.8b,c,d | 11.2 ± 0.8a | 11.3 ± 1.1a | 10.6 ± 1.0a | Tamhane test |
Table 4 Demographics and examination findings of the dry eye patients grouped by Schirmer test with or without type 2 diabetes mellitus
Parameters | DEwDM | P value | DEnDM | P value | DEwDM versus DEnDM P value | |||
Schirmer test ≤ 5 mm | Schirmer test > 5 mm | Schirmer test ≤ 5 mm | Schirmer test > 5 mm | Schirmer test ≤ 5 mm | Schirmer test > 5 mm | |||
Number [N] | 39 | 17 | 24 | 9 | ||||
Age [yr ± SEM] | 57.1 ± 8.5 | 57.9 ± 7.2 | 0.707 | 53.5 ± 11.7 | 49.1 ± 9.0 | 0.323 | 0.164 | 0.011 |
Gender | 0.686 | 0.122a | 0.632b | 0.026a | ||||
Male [N (%)] | 23 (59.0) | 11 (64.7) | 8 (33.3) | 6 (66.7) | ||||
Female [N (%)] | 16 (41.0) | 6 (35.3) | 16 (66.7) | 3 (33.3) | ||||
Blood glucose [mmol/L ± SEM] | 8.8 ± 3.6 | 8.9 ± 5.0 | 0.893 | NA | NA | NA | ||
13.5 ± 6.8 | 9.5 ± 7.4 | 0.054 | NA | NA | NA | |||
HbA1c [% ± SEM] | 8.1 ± 1.8 | 8.1 ± 2.5 | 0.995 | NA | NA | NA | ||
BUT [s ± SEM] | 4.3 ± 2.9 | 3.1 ± 1.0 | 0.105 | 5.6 ± 4.3 | 3.2 ± 1.3 | 0.114 | 0.153 | 0.856 |
Schirmer test [mm ± SEM] | 2.1 ± 1.7 | 9.9 ± 3.1 | 0.000 | 1.9 ± 1.5 | 8.7 ± 2.5 | 0.000 | 0.590 | 0.319 |
NFL [mm/mm2 ± SEM] | 16.671 ± 4.749 | 16.727 ± 5.006 | 0.968 | 17.036 ± 4.691 | 16.514 ± 5.549 | 0.788 | 0.767 | 0.922 |
NFD [num/mm2 ± SEM] | 32.4 ± 9.7 | 30.1 ± 11.7 | 0.310 | 35.7 ± 8.3 | 34.7 ± 16.3 | 0.429 | 0.072 | 0.039 |
NBD [num/mm2 ± SEM] | 52.1 ± 22.9 | 55.5 ± 30.9 | 0.241 | 65.6 ± 23.7 | 49.3 ± 22.2 | 0.019 | 0.031 | 0.104 |
R1 [ms ± SEM] | 12.1 ± 0.9 | 11.8 ± 0.6 | 0.406 | 11.1 ± 0.8 | 11.5 ± 0.9 | 0.288 | 0.000 | 0.215 |
Table 5 Correlation analysis of each observation index
Group | HbA1c | P value related to R1 | P value related to Schirmer | P value related to BUT | P value related to NFL | P value related to NFD | P value related to NBD |
Diabetes groups | 8.08 ± 1.89 | 0.072 | 0.280 | 0.796 | 0.621 | 0.794 | 0.952 |
Diabetic dry eye group | 8.14 ± 2.01 | 0.933 | 0.508 | 0.141 | 0.589 | 0.823 | 0.851 |
Diabetic non-dry eye group | 7.93 ± 1.57 | 0.419 | 0.376 | 0.140 | 0.910 | 0.421 | 0.832 |
- Citation: Fang W, Lin ZX, Yang HQ, Zhao L, Liu DC, Pan ZQ. Changes in corneal nerve morphology and function in patients with dry eyes having type 2 diabetes. World J Clin Cases 2022; 10(10): 3014-3026
- URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3014.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3014